LASSBio-1799

N/A

Report date: 2023/06/28 14:04:19
NME

Base Information

Drug NameLASSBio-1799
Drug Alias NameLASSBio-1799
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-kinase inhibitors
TargetsPhosphatidylinositol 4-kinase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFederal University of Rio de Janeiro
China Registration ClassN/A

Develop Information

Active CompaniesFederal University of Rio de Janeiro
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A